Van Anh Nguyen Selected Research

Van Anh Nguyen Research Topics

Disease

10	Neoplasms (Cancer) 06/2023 - 12/2002
7	Melanoma (Melanoma, Malignant) 05/2023 - 09/2017
2	Necrosis 01/2022 - 09/2011
2	Muscular Diseases (Myopathy) 01/2012 - 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024
1	Skin Neoplasms (Skin Cancer) 05/2023
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2023
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Multiple Myeloma 10/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2020
1	Fever (Fevers) 12/2020
1	Infections 12/2020
1	Brain Neoplasms (Brain Tumor) 08/2020
1	Neoplasm Metastasis (Metastasis) 07/2020
1	Hemangiosarcoma (Angiosarcoma) 07/2020
1	Arthritis (Polyarthritis) 01/2020
1	Disease Progression 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2019
1	Neutropenia 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Pyoderma Gangrenosum 04/2016
1	Mycosis Fungoides 05/2012
1	Atrophy 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2012
1	Demyelinating Diseases (Demyelinating Disease) 01/2012
1	Atherosclerotic Plaque (Atheroma) 06/2010
1	digital ulcers 03/2010
1	Systemic Scleroderma (Systemic Sclerosis) 03/2010
1	Pain (Aches) 03/2010
1	Hemangioma (Angioma) 06/2004

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2016
3	NivolumabIBA 05/2023 - 10/2018
2	AntibodiesIBA 05/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2020
2	IpilimumabIBA 01/2020 - 10/2018
2	Insulin (Novolin)FDA Link 01/2012 - 01/2012
1	Monoclonal AntibodiesIBA 03/2024
1	pembrolizumabIBA 05/2023
1	FRAX597IBA 12/2022
1	Phosphotransferases (Kinase)IBA 12/2022
1	epacadostatIBA 01/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	Bortezomib (Velcade)FDA Link 10/2021
1	Vorinostat FDA Link 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Peptides (Polypeptides)IBA 11/2020
1	fotemustine (Muphoran)IBA 11/2020
1	Dacarbazine (DIC)FDA LinkGeneric 11/2020
1	130-nm albumin-bound paclitaxelIBA 07/2020
1	atezolizumabIBA 01/2020
1	AntigensIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2018
1	raf KinasesIBA 09/2017
1	Phosphatidylethanolamine Binding ProteinIBA 09/2017
1	VaccinesIBA 09/2017
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 05/2012
1	C-Type Lectins (C-Type Lectin)IBA 05/2012
1	Ethanol (Ethyl Alcohol)IBA 01/2012
1	AcetylcholinesteraseIBA 01/2012
1	Cytoskeletal ProteinsIBA 01/2012
1	InterleukinsIBA 09/2011
1	ProstaglandinsIBA 09/2011
1	Interleukin-6 (Interleukin 6)IBA 09/2011
1	CytokinesIBA 09/2011
1	arginyl-glycyl-aspartic acidIBA 06/2010
1	CholesterolIBA 06/2010
1	HDL LipoproteinsIBA 06/2010
1	Endothelin Receptor AntagonistsIBA 03/2010
1	Bosentan (Tracleer)FDA Link 03/2010
1	HLA-DR Antigens (HLA-DR)IBA 06/2004
1	IntegrinsIBA 06/2004

Therapy/Procedure

5	Immunotherapy 01/2020 - 12/2002
4	Therapeutics 05/2023 - 01/2016
2	Aftercare (After-Treatment) 01/2020 - 10/2018
1	Treatment Delay 05/2022
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022
1	Drug Therapy (Chemotherapy) 11/2020
1	Skin Transplantation (Skin Grafting) 04/2016
1	Negative-Pressure Wound Therapy 04/2016
1	Denervation 01/2012
1	Ligation 09/2011